title: An Inflammatory Skin Reaction After Cetuximab Treatment for Aggressive Cutaneous Squamous Cell Carcinoma in a Heart Transplant Patient Previously Taking Voriconazole.
authors.affiliation: Rutgers Robert Wood Johnson Medical School, Somerset, New Jersey.
authors.forename: Danielle
authors.initials: D
authors.lastname: Giambrone
authors.affiliation: Rutgers Robert Wood Johnson Medical School, Somerset, New Jersey.
authors.forename: Lilia M
authors.initials: LM
authors.lastname: Correa-Selm
authors.affiliation: Rutgers Robert Wood Johnson Medical School, Somerset, New Jersey.
authors.forename: Bahar F
authors.initials: BF
authors.lastname: Firoz
mesh_terms: D000074322:Antineoplastic Agents, Immunological / Q000008:administration & dosage / Q000009:adverse effects; D001706:Biopsy; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000188:drug therapy*; D000068818:Cetuximab / Q000008:administration & dosage / Q000009:adverse effects*; D065692:Cytochrome P-450 CYP3A Inhibitors / Q000494:pharmacology; D003872:Dermatitis / Q000175:diagnosis / Q000209:etiology*; D016027:Heart Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012867:Skin / Q000187:drug effects / Q000473:pathology*; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D065819:Voriconazole / Q000494:pharmacology*
chemical_list: D000074322:Antineoplastic Agents, Immunological; D065692:Cytochrome P-450 CYP3A Inhibitors; D065819:Voriconazole; D000068818:Cetuximab